ArticleTranslational pediatrics2026
Machine learning-based prediction of severe
Article in Translational pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Methods: Clinical data from 123 patients in the mild MPP group and 284 patients in the severe MPP group were analyzed retrospectively. The least absolute shrinkage and selection operator (LASSO) was applied to identify key clinical variables. Eight ML algorithms were compared, and the model with the highest area under the curve (AUC) was selected for risk prediction. SHapley Additive exPlanations (SHAP) were used to interpret the model results. Results: The random forest (RF) model demonstrated optimal performance for predicting the individual risk of severe MPP, with an accuracy of 0.92, specificity of 0.91, recall of 0.91, and F1 score of 0.91. SHAP analysis indicated that the factors most strongly associated with severe MPP included length of hospital stay, month of admission, and serum creatinine (Cr) levels, among others. Conclusions: Eight ML models were developed to predict the individual risk of severe MPP. The RF model exhibited superior performance among the algorithms tested. This approach enabled accurate prediction of severe MPP in pediatric patients and facilitated the identification of key clinical factors associated with disease severity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.